Beersel, Belgium

Marc Parmentier

This inventor holds 26 USPTO granted patents, plus 1 CIPO patent and 4 EPO patents, primarily in Chemerin Receptor Research. Top assignees: Euroscreen S.a., B.r.a.h.m.s. Diagnostica Gmbh, Other. Active years: 2001-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc Parmentier. Retrieved from https://idiyas.com/inventor/marc-parmentier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 61.5



Average Co-Inventor Count = 5.5

ph-index = 6

Forward Citations = 89(Granted Patents)


Location History:

  • Linebeek, BE (2005)
  • Linkebeek, BE (2002 - 2007)
  • Brusselsl, BE (2008)
  • Beersel, BE (2007 - 2010)
  • Brussels, BE (2001 - 2011)
  • Beerzel, BE (2010 - 2011)

Company Filing History:


Years Active: 2001-2011

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Chemerin Polypeptide
Monoclonal Antibodies
G-Protein Coupled Receptors
CCR5 Chemokine Receptor
Nucleic Acids
HIV Entry
Functional Antibodies
Ligands
High-Throughput Screening
Agonists
Antagonists
Polypeptides
26 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marc Parmentier

Introduction

Marc Parmentier, a notable inventor based in Beersel, Belgium, has made significant contributions to the field of biotechnology. With a remarkable portfolio of 26 patents, his work primarily focuses on the development of novel ligands and screening methods related to G-protein coupled receptors, which play a crucial role in various biological processes.

Latest Patents

Among Parmentier's most recent innovations are two pivotal patents:

1. **Methods of making an antibody that binds a chemerin polypeptide**: This invention delves into the realm of G-protein coupled receptors, providing valuable screening assays that aid in the identification of compounds capable of modulating receptor activity. The implications of this patent extend to diagnosing and treating diseases associated with receptor signaling dysregulation.

2. **Nucleic acids encoding ChemerinR ligands**: Similar to his first patent, this invention also addresses G-protein coupled receptors and introduces a novel ligand. It underscores the importance of identifying candidate compounds that can influence receptor activity, enhancing the potential for therapeutic interventions in related disorders.

Career Highlights

Throughout his career, Marc Parmentier has been associated with esteemed companies, notably Euroscreen S.A., where he has further refined his expertise in biotechnological innovations. His relentless pursuit of scientific advancement has led to numerous breakthroughs that contribute to the understanding and manipulation of cellular signaling.

Collaborations

In his journey as an inventor, Parmentier has collaborated with notable colleagues, including Gilbert Vassart and Michel Detheux. These partnerships have fostered an environment of shared knowledge and innovation, amplifying the impact of their collective research on the field.

Conclusion

Marc Parmentier exemplifies the spirit of innovation within the biotechnology sector. His extensive patent portfolio not only showcases his ingenuity but also his commitment to advancing medical science through the understanding of receptor signaling. As he continues to contribute to this critical area of research, Parmentier's work holds great promise for future therapeutic advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…